Authors: Gallou, C Longuemaux, S Delomenie, C Mejean, A Martin, N Martinet, SP Palais, G Bouvier, R Droz, D Krishnamoorthy, R Junien, C Beroud, C Dupret, JM

Citation: C. Gallou et al., Association of GSTT1 non-null and NAT1 slow/rapid genotypes with von Hippel-Lindau tumour suppressor gene transversions in sporadic renal cell carcinoma, PHARMACOGEN, 11(6), 2001, pp. 521-535

Authors: Rodrigues-Lima, F Delomenie, C Goodfellow, GH Grant, DM Dupret, JM

Citation: F. Rodrigues-lima et al., Homology modelling and structural analysis of human arylamine N-acetyltransferase NAT1: evidence for the conservation of a cysteine protease catalytic domain and an active-site loop, BIOCHEM J, 356, 2001, pp. 327-334

Authors: Delomenie, C Fouix, S Longuemaux, S Brahimi, N Bizet, C Picard, B Denamur, E Dupret, JM

Citation: C. Delomenie et al., Identification and functional characterization of arylamine N-acetyltransferases in eubacteria: Evidence for highly selective acetylation of 5-aminosalicylic acid, J BACT, 183(11), 2001, pp. 3417-3427

Authors: Fabrega, SL Durand, P Codogno, P Bauvy, C Delomenie, C Henrissat, B Martin, BM McKinney, C Ginns, EI Mornon, JP Lehn, P

Citation: Sl. Fabrega et al., Human glucocerebrosidase: heterologous expression of active site mutants in murine null cells, GLYCOBIOLOG, 10(11), 2000, pp. 1217-1224

Authors: Longuemaux, S Delomenie, C Gallou, C Mejean, A Vincent-Viry, M Bouvier, R Droz, D Krishnamoorthy, R Galteau, MM Junien, C Beroud, C Dupret, JM

Citation: S. Longuemaux et al., Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: A study of polymorphic human xenobiotic-metabolizing enzymes, CANCER RES, 59(12), 1999, pp. 2903-2908